2017;99:269 76. 119. Ruppar TM, Cooper PS, Mehr DR, et al. Medication adherence interventions improve heart failure mortal- ity and readmission rates: systematic review and meta- analysis of controlled trials. J Am Heart Assoc. 2016;5: e002606. 120. Gandhi S, Chen S, Hong L, et al. Effect of mobile health interventions on the secondary prevention of cardiovascular disease: systematic review and meta- analysis. Can J Cardiol. 2017;33:219 31. 121. Maddison R, Rawstorn JC, Shariful Islam SM, et al. mHealth interventions for exercise and risk factor modi cation in cardiovascular disease. Exerc Sport Sci Rev. 2019;47:86 90. 122. Cutler DM, Everett W. Thinking outside the pillbox medication adherence as a priority for health care reform. N Engl J Med. 2010;362:1553 5. 123. MacLaughlin EJ, Raehl CL, Treadway AK, et al. Assessing medication adherence in the elderly: which tools to use in clinical practice? Drugs Aging. 2005;22: 231 55. 124. Blood AJ, Fischer CM, Fera LE, et al. Rationale and design of a navigator-driven remote optimization of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction. Clin Car- diol. 2020;43:4 13. 125. Fonarow GC, Albert NM, Curtis AB, et al. Improving evidence-based care for heart failure in outpatient cardiology practices: primary results of the registry to improve the use of evidence-based heart failure therapies in the outpatient setting (IMPROVE HF). Circulation. 2010;122:585 96. 126. Wurmbach VS, Schmidt SJ, Lampert A, et al. Development of an algorithm to detect and reduce complexity of drug treatment and its technical real- isation. BMC Med Inform Decis Mak. 2020;20:154. 127. Driscoll A, Currey J, Tonkin AM. Nurse-led titration of angiotensin-converting enzyme inhibitors, beta- adrenergic blocking agents, and angiotensin receptor blockers in patients with heart failure with reduced ejection fraction. JAMA Cardiol. 2016;1:842 3. 128. Lowrie R, Mair FS, Greenlaw N, et al. 